Matches 1 - 50 out of 77 1 2 >
Match Document Document Title
7491849 Oligoamine compounds and derivatives thereof for cancer therapy  
Oligoamine compounds with anti-cancer and anti-proliferative activity are provided, as well as methods for making and using the compounds. The compounds are shown to be active against prostate...
7459446 Treatment of diabetes with copper binding compounds  
Novel methods of treating a patient for diseases, disorders, and conditions including diabetes mellitus, comprising administering, for example, copper binding compounds.
7453011 Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor  
Conformationally restricted polyamine compounds useful in treatment of cancer and other diseases marked by abnormal cell proliferation are disclosed. Improved methods of synthesizing such compounds...
7423182 Aminated polyamines  
An aminated polyamine having the formula: or its possible stereoisomers or a salt thereof with a pharmaceutically acceptable acid wherein: R 1 and R 4 may be the same or different and...
7414154 Polyamine compounds and compositions for use in conjunction with cancer therapy  
The invention provides novel polyamine compounds and pharmaceutical compositions for administration in conjunction with cancer chemotherapy or radiation therapy. The compounds are administered...
7279502 Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases  
Peptide conjugates in which cytocidal and cytostatic agents, such as polyamine analogs or naphthoquinones, are conjugated to a polypeptide recognized and cleaved by enzymes such as...
7273888 Use of difluoromethylornithine (DFMO) for the treatment of amyotrophic lateral sclerosis  
The present invention provides methods and compositions for modulating polyamine pathway activity as a means for ameliorating neurodegenarative disorders. In particular, for ameliorating the...
7232846 Amines as anti-alcoholism agents  
The oral administration to genetically alcoholic rats (from the strain UChB of the University of Chile) of a compound selected from endogenic polyamines (putrescine, spermidine, spermine),...
7202280 Methods for the treatment and prevention of pancreatitis and for induction of liver regeneration  
Novel methods for treating and preventing acute and/or chronic pancreatitis are described. Additionally, novel methods for inducing liver regeneration are described. The methods may comprise...
7094808 Analogs of biologically active, naturally occurring polyamines, pharmaceutical compositions and methods of treatment  
Polyamines having the formula: or a salt thereof with a pharmaceutically acceptable acid wherein: R 1 -R 6 may be the same or different and are alkyl, aryl, aryl alkyl, cycloalkyl, optionally...
7087648 Methods for modulating macrophage proliferation using polyamine analogs  
Methods for modulating macrophage proliferation in an individual afflicted with or at risk for a macrophage-associated disease are provided. The methods employ a polyamine analog, or salt or...
7045550 Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy  
Polyamine effectors are administered locally to provide protection against the adverse side-effects of chemotherapy or radiation therapy, such as alopecia, mucositis and dermatitis. Pharmaceutical...
7008531 Treatment of circulating water systems  
The present invention relates to a method of inhibiting the growth of killing algae, bacteria, yeast and/or fungi in a recirculating water system which comprises adding to the water a polymeric...
6897243 Fructosamine oxidase: antagonists and inhibitors  
The present invention relates to methods of treating an individual with diabetes mellitus by administering to said individual an effective amount of copper chelators, hydrazine compounds, and/or...
6867237 DNA encoding apoptosis-induced eucaryotic initiation factor-5A and deoxyhypusine synthase and a method for controlling apoptosis in animals and humans  
Genes encoding an apoptosis-induced eukaryotic initiation Factor-5A (eIF-5A) and an apoptosis-induced deoxyhypusine synthase (DHS), whose expressions are induced by the onset of apoptosis, are...
6849648 Phenylene alkyne matrix metalloproteinase inhibitors  
A compound of Formula I or a pharmaceutically acceptable salt thereof, or a tautomer thereof, wherein G 1 , G 2 , and B are as defined in the application, are selective inhibitors of...
6841576 Anti-hypertensive composition and methods of treatment  
Pharmaceutical compositions for the treatment of hypertension comprising an effective anti-hypertensive amount of at least one compound in association with a pharmaceutically acceptable,...
6649587 Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases  
Peptide conjugates in which cytocidal and cytostatic agents, such as polyamine analogs or naphthoquinones, are conjugated to a polypeptide recognized and cleaved by enzymes such as...
6586478 Methods and compositions for improving sleep  
Methods and compositions for improving sleep in individuals with sleep disorders or other conditions which interfere with normal sleep via administration of a NO-mimetic are provided.
6576672 Polyamine treatment of neurological disorders  
2,3,2 Tetramine (3,7-diazanonane-1,9-diamine) is propounded for treatment of Parkingson's Disease and dementias characterized by mitochondrial damage in view of this compound's ability to...
6531512 Method of treating cancer in patients having a deficiency in p53 tumor suppressor gene  
A method of treating cancer in a patient deficient in p53 tumor suppression gene is described herein by administering to a patient a therapeutically effective amount if a polyamine such as DENSPM...
6482833 Immunotherapeutic anti-cancer pharmaceutical compositions  
There is disclosed a class of pharmaceutical compositions useful for the treatment of cancer, particularly solid tumors, and having a mechanism of action as spermine antagonists. The present...
6464764 Protective agents for wood  
Solvent-free coating materials and treating agents used as water-based wood or material protective agents containing emulsifiable binding agents, quaternary ammonium compounds and optional...
6444230 Synergistic composition of peracetic acid and amine oxide  
Composition in the form of an aqueous solution, useful for disinfecting hard surfaces comprises: a) from 0.0005% to 20% by weight of peracetic acid, b) from 0.001% to 45% by weight of acetic acid,...
6399662 Method and composition for the treatment of diarrhea and gastrointestinal spasms  
Anti-diarrheal and/or gastrointestinal anti-spasmodic pharmaceutical compositions containing [A] a polyamine of the formula: R 1 —N 1 (R 2 )—(CH 2 )x—N 2 H—Q—N 3 H—(CH 2 )y—N 4 (R 3...
6362232 Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives  
The present invention relates to anti-neoplastic and anti-psoriasis pharmaceutical compositions and methods of treatment and to insecticidal compositions and methods of controlling the growth of...
6342534 Analogs of biologically active, naturally occurring polyamines, pharmaceutical compositions and methods of treatment  
Polyamines having the formula: or a salt thereof with a pharmaceutically acceptable acid wherein: R 1 -R 6 may be the same or different and are alkyl, aryl, aryl alkyl, cycloalkyl, optionally...
6274630 Method of inhibiting biosynthesis of EIf5A  
A method and pharmaceutical composition for inhibiting or preventing the intracellular biosynthesis of EIf5A by the administration to a human or non-human mammal in need thereof an amount of a...
6235794 Biologically active spermidine analogues, pharmaceutical compositions and methods of treatment  
Polyamines having the formula: ##STR1## or a salt thereof with a pharmaceutically acceptable acid wherein: R 1 -R 5 may be the same or different and are alkyl, aryl, aryl alkyl, cycloalkyl or...
6217914 Ascorbic acid composition and method for treatment of aging or damaged skin  
An ascorbic acid-based composition and related method for the treatment of aging or photo-damaged skin is disclosed. The composition includes water and ascorbic acid, at least a portion of which...
6184254 Methods of identifying modulators of perivascular sensory nerve Ca2+ receptors  
Methods of identifying compounds that relax or stimulate arterial tension through their action on perivascular sensory nerve calcium receptors are described. Compounds identified through such...
6168808 Synergistic composition of peracetic acid and amine oxide  
Composition in the form of an aqueous solution, useful for disinfecting hard surfaces comprises: a) from 0.0005% to 20% by weight of peracetic acid, b) from 0.001% to 45% by weight of acetic...
6160022 Chemical resection of pancreas  
A method of chemically resecting the exocrine portion of the pancreas of a patient in need thereof comprising administering to the patient an amount of a hydroxy polyamine or a salt thereof with a...
6015828 Chemical modification of chloride channels as a treatment for cystic fibrosis and other diseases  
This invention relates generally to medical treatment methods. Specifically, the invention relates to methodology for the correction of defective chloride transport by activation of chloride...
6011066 Method for treating septic shock  
A method for the treating septic shock in a patient comprises administering to the patient a therapeutically-effective amount of a composition comprising a compound having the formula (I): ##STR1##...
5962533 Hydroxy polyamines  
Disclosed are polyamines having the formula: ##STR1## or salts or stereoisomers thereof wherein R 1 -R 4 and ALK 1 -ALK 3 are as defined in the specification. Pharmaceutical compositions and...
5935518 Swimming pool treatment  
This invention relates to the treatment of pool surfaces and equipment with antimicrobial solutions which contain straight chain alkylamine compounds alone or in combination with additional...
5929039 Method for treating cardiac dysfunction and pharmaceutical compositions useful therefor  
The present invention relates generally to a method for, and pharmaceutical compositions useful in, the prophylaxis and/or treatment of cardiac dysfunction in a mammal by the administration of an...
5906996 Tetramine treatment of neurological disorders  
2,3,2 Tetramine (3,7-diazanonane-1,9-diamine) is propounded for the treatment of Parkinson's Disease and dementias characterized by mitochondrial damage in view of this compound's ability to...
5886051 Methods and compositions for the treatment of neurodegeneration  
Methods and pharmaceutical compositions in unit dosage form for treating neurodegeneration in a human or non-human animal afflicted therewith wherein the active agent is a therapeutically effective...
5880161 Therapeutic polyamines  
Therapeutic polyamines useful as a cancer chemotherapeutic agents, including molecules having a formula R 1 --NH--(CH 2 ) x --NH-- (CH 2 ) x --NH-- (CH 2 ) y --NH--(CH 2 ) z --NH--R, wherein R...
5776352 Process for treatment of water and of surfaces in contact with the said water in order to prevent the attachment of and/or to remove and/or to control macroorganisms, composition and paint for the said treatment  
The invention relates to a process for the treatment of water and of surfaces in contact with the said water in order to prevent the attachment and/or to, remove and/or to control macroorganisms,...
5760092 Allocolchinones and uses thereof  
Disclosed are allocolchinones, which are anti-mitotic agents. Allocolchinones bind to tubulin reversibly and are more effective at inhibiting microtubule formation than colchicine....
5760091 Preventive agents against adhesion of marine organisms and methods of preventing such adhesion of marine organisms  
A preventive agent against adhesion of a marine organism comprising: at least one amine compound represented by the following formula (I): ##STR1## , wherein R is a C 8 -22 saturated or unsaturated...
5719193 Method of potentiating cell-mediated immunity utilizing polyamine derivatives  
This invention relates to a method of potentiating cell-mediated immunity which comprises administering to a patient a cell-mediated immunity potentiating amount of a compound of the formula: ...
5654287 Method of treating cancer by conjunctive therapy with N,N.sup.1 -bis[3-(ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent  
The present invention relates to a method of treating a patient suffering from a neoplastic disease state comprising administering to said patient an effective antineoplastic amount of...
5627215 Unsaturate amino compounds for use as anticancer and antiprotozoic agent  
The invention relates to compounds of formula (I), R 1 and R 2 , each independently of the other, are selected from lower alkyl that is unsubstituted or substituted by one or more fluorine atoms...
5614509 Pharmaceutical agents for preventing the development of tolerance during the treatment with benzodiazepine-receptor-binding active ingredients  
The use of NMDA receptor antagonists or their physiologically compatible salts for preventing the development of tolerance during the long-term treatment with benzodiazepine-receptor-binding active...
5554656 Disinfectant concentrates and disinfectants on amine and alcohol base and their use  
The invention relates to a disinfectant concentrate which contains amine and alcohol wherein the alcohol component includes at least one glycol ether of limited miscibility with water and the amine...
5498522 Methods for the use of spermidine/spermine N.sup.1 -acetyltransferase as a prognostic indicator and/or a tumor response marker  
Disclosed is a method that relates to the measurement of determinants related to the in-vivo induction of spermidine/spermine N 1 -acetyltransferase (SSAT), subsequent to polyamine analog...
Matches 1 - 50 out of 77 1 2 >